Bionano Genomics, Inc. (BNGO) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bionano Genomics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.000 -- 00:00:04.620 the BioNano Second Quarter 2025 earnings conference call. 00:00:04.620 -- 00:00:09.220 Today's conference is being recorded. At this time, I would like to turn the conference 00:00:09.220 -- 00:00:12.120 over to Kelly Gura from Investor Relations. 00:00:12.120 -- 00:00:14.560 Please go ahead. 00:00:14.600 -- 00:00:19.880 Thank you and good afternoon, everyone. Welcome to the BioNano Second Quarter 2025 financial 00:00:19.880 -- 00:00:23.180 results conference call. Leading the call today is Dr. 00:00:23.180 -- 00:00:28.200 Eric Homelin, CEO and Principal Financial Officer of BioNano, and he is joined by 00:00:28.200 -- 00:00:34.220 Mark Adamczak, BioNano's Vice President of Accounting and Principal Accounting Officer. 00:00:34.220 -- 00:00:38.600 After market closed today, BioNano issued a press release announcing its financial results 00:00:38.600 -- 00:00:41.120 for the second quarter of 2025. 00:00:41.120 -- 00:00:46.540 A copy of the release can be found on the Investor Relations page of the company's website. 00:00:47.240 -- 00:00:51.040 Certain statements made during this conference call may be forward-looking statements. 00:00:51.040 -- 00:00:55.140 Actual results may differ materially from such statements due to several factors and 00:00:55.140 -- 00:00:59.420 risks, some of which are identified in BioNano's press release and BioNano's reports 00:00:59.420 -- 00:01:01.560 filed with the SEC. 00:01:01.560 -- 00:01:05.660 These forward-looking statements are based on information available to BioNano today, 00:01:05.660 -- 00:01:11.020 August 14th, 2025, and the company assumes no obligation to update statements as circumstances 00:01:11.020 -- 00:01:12.940 change. 00:01:12.940 -- 00:01:17.960 During our call, we may reference...